AzTrials
AzTrials

Condition

Unspecified Adult Solid Tumor, Protocol Specific Clinical Trials

Studies of unspecified adult solid tumor, protocol specific, matched by condition name and medical subject headings. Start with those open to enrolment.

759 registered studies

In numbers

Open to volunteers
6
Active
10
With results posted
79
All registered
759

Open to volunteers: recruiting, not yet recruiting or enrolling by invitation. Active adds studies under way that have stopped recruiting.

Open to volunteers

All 6
  • Unspecified Adult Solid Tumor, Protocol Specific

    Copenhagen Prospective Personalized Oncology (CoPPO)

    • Recruiting
    • Age: 18 years and older
    • Surgery or procedure

    Patients with advanced solid tumors referred to the Phase 1 Unit are offered mapping of GA for identification of pts who could benefit from a personalized treatment.

    Trial name
    CoPPO (NCT02290522)
    Testing
    Tumor biopsy
    Where
    Denmark
    Volunteers
    500 people
    Sponsor
    Ulrik Lassen
    Can I take part? CoPPO
  • Unspecified Adult Solid Tumor, Protocol Specific

    Collecting Tissue Samples From Patients With Cancer Undergoing Radiation Therapy and Healthy Participants

    • Recruiting
    • Age: 18 years and older
    • Observational study

    RATIONALE: Collecting and storing samples of tissue from patients with cancer to test in the laboratory may help the study of cancer in the future.

    Trial name
    NCT00992303
    Testing
    biologic sample preservation procedure, medical chart review, questionnaire administration
    Where
    United States
    Volunteers
    10,000 people, healthy volunteers welcome
    Sponsor
    University of Texas Southwestern Medical Center
    Can I take part? NCT00992303
  • Chronic Myeloproliferative Disorders, Cognitive/Functional Effects

    Registry of Older Patients With Cancer

    • Recruiting
    • Age: 65 years and older
    • Observational study

    RATIONALE: Gathering information about older patients with cancer may help the study of cancer in the future. PURPOSE: This research study is gathering information from older patients with cancer into a registry.

    Conditions
    Chronic Myeloproliferative Disorders, Cognitive/Functional Effects, Leukemia, Lymphoma
    Trial name
    NCT01137825
    Where
    7 sites in United States
    Volunteers
    3,000 people
    Sponsor
    UNC Lineberger Comprehensive Cancer Center
    Can I take part? NCT01137825
  • Unspecified Adult Solid Tumor, Protocol Specific, Unspecified Childhood Solid Tumor, Protocol Specific

    Collection and Storage of Tissue Samples From Patients Undergoing Surgery For Suspected Solid Tumors

    • Recruiting
    • Age: 18 to 120 years
    • Observational study

    RATIONALE: Collecting and storing samples of tissue or blood from patients with cancer for study in the laboratory may help the study of cancer in the future PURPOSE: This research study is collecting and storing blood and tissue…

    Trial name
    NCT00900471
    Testing
    biologic sample preservation procedure, medical chart review
    Where
    United States
    Volunteers
    20,000 people
    Sponsor
    Wake Forest University Health Sciences
    Can I take part? NCT00900471
  • Unspecified Adult Solid Tumor, Protocol Specific

    Genomic Profiling in Recommending Treatment for Patients With Metastatic Solid Tumors

    • Recruiting
    • Age: 18 years and older
    • Observational study

    This research trial studies using genomic profiling to recommend anticancer treatment to patients with cancer that has spread beyond the original site of the tumor (metastatic cancer).

    Trial name
    NCT02215928
    Testing
    mutation analysis, cytology specimen collection procedure, laboratory biomarker analysis
    Where
    United States
    Volunteers
    100 people
    Sponsor
    Stanford University
    Can I take part? NCT02215928
  • Unspecified Adult Solid Tumor, Protocol Specific

    Phase 1/2 Clinical Trial of CP-506 (HAP) in Monotherapy or With Carboplatin or ICI

    • Recruiting
    • Age: 18 years and older
    • Phase 1/2
    • Pill or oral medicine

    A modular, first time in human, open label, multiple dose, accelerated escalation with cohort expansion study of the safety and pharmacokinetics of intravenous infusion of CP-506, a tumor agnostic Hypoxia Activated Prodrug in…

    Trial name
    NCT04954599
    Testing
    CP-506, Carboplatin, Immune checkpoint inhibitor
    Where
    5 sites in Belgium, Netherlands and 1 more
    Volunteers
    126 people
    Sponsor
    Maastricht University Medical Center

Completed, with results posted

All –

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in